Last Updated: October 2, 2026

Details for Patent: 5,886,035

Name: Drug Patent Intelligence for US Patent 5886035
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,886,035

Title:	Difluoroprostaglandin derivatives and their use
Abstract:	A fluorine-containing prostaglandin derivative of the formula (1) (or a salt thereof) and a medicine containing it, particularly, a preventive or therapeutic medicine for an eye disease: (1) wherein A is a vinylene group or the like, R1 is an aryloxyalkyl group or the like, R2 and R3 are hydrogen atoms or the like, and Z is OR4 (wherein OR4 is a hydrogen atom or an alkyl group) or the like.
Inventor(s):	Eiichi Shirasawa, Masaaki Kageyama, Tadashi Nakajima, Takashi Nakano, Nobuaki Mori, Hideshi Sasakura, Yasushi Matsumura, Yoshitomi Morizawa
Assignee:	Santen Pharmaceutical Co Ltd , AGC Inc
Application Number:	US08/993,017
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 5,886,035
Patent Claim Types: see list of patent claims	Use; Compound;

Drugs Protected by US Patent 5,886,035

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 5,886,035

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	8-348614	Dec 26, 1996
Japan	9-074054	Mar 26, 1997
Japan	9-172477	Jun 27, 1997

International Family Members for US Patent 5,886,035

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0850926	⤷ Start Trial	CA 2008 00041	Denmark	⤷ Start Trial
European Patent Office	0850926	⤷ Start Trial	300407	Netherlands	⤷ Start Trial
European Patent Office	0850926	⤷ Start Trial	SPC/GB09/005	United Kingdom	⤷ Start Trial
European Patent Office	0850926	⤷ Start Trial	SPC013/2011	Ireland	⤷ Start Trial
European Patent Office	0850926	⤷ Start Trial	11C0020	France	⤷ Start Trial
European Patent Office	0850926	⤷ Start Trial	339	Finland	⤷ Start Trial
European Patent Office	0850926	⤷ Start Trial	91943	Luxembourg	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.